SCI 및 Peer-Reviewed 저널 논문 게재
1. Kim JY, Shin D, Lee G, Kim JM, Kim D, An YM, Yoo BR, Chang H, Kim M, Cho J (Co-corresponding author), Bae H. Standardized Herbal Formula PM014 Inhibits Radiation-Induced Pulmonary Inflammation in Mice. Sci Rep. 2017 Mar 21;7:45001. doi: 10.1038/srep45001.
2. Shin D, Lee G, Lee S, Park S, Jung KH, Lee JH, Lee JM, Kim JY, Cho J (Co-corresponding author), Bae H. Adenovirus-mediated Foxp3 expression in lung epithelial cells ameliorates acute radiation-induced pneumonitis in mice. Gene Ther. Gene Ther. 2017 Feb;24(2):104-112. doi: 10.1038/gt.2016.86.
3. Kim JY, An YM, Choi WH, Kim JM, Cho S, Yoo BR, Kang JW, Lee YS, Lee YJ, Cho J. Pro-apoptotic Noxa is involved in ablative focal irradiation-induced lung injury. J Cell Mol Med. 2016 Nov 15. doi: 10.1111/jcmm.13014. [Epub ahead of print]
4. Jin H, Jeon S, Kang GY, Lee HJ, Cho J, Lee YS. Identification of Radiation Response Genes and Proteins from Mouse Pulmonary Tissues after High-Dose per Fraction Irradiation of Limited Lung Volumes. Int J Radiat Biol. Int J Radiat Biol. 2017 Feb;93(2):184-193. doi: 10.1080/09553002.2017.1235297.
5. Kim JW, Suh CO, Hong CK, Kim EH, Lee IJ, Cho J, Lee KS. Maximum surgical resection and adjuvant intensity-modulated radiotherapy with simultaneous integrated boost for skull base chordoma. Acta Neurochir (Wien). 2016 Aug 9. [Epub ahead of print]
6. Kim TH, Kim JS, Suh YG, Cho J, Yang WI, Suh CO. The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma. Yonsei Med J. 2016 Jul;57(4):846-54. doi: 10.3349/ymj.2016.57.4.846.
7. Lee J, Cho J, Chang JH, Suh CO. Re-Irradiation for Recurrent Gliomas: Treatment Outcomes and Prognostic Factors. Yonsei Med J. 2016 Jul;57(4):824-30. doi: 10.3349/ymj.2016.57.4.824.
8. Kwon OS, Kim KT, Lee E, Kim M, Choi SH, Li H, Fornace AJ Jr, Cho JH, Lee YS, Lee JS, Lee YJ, Cha HJ. Induction of MiR-21 by Stereotactic Body Radiotherapy Contributes to the Pulmonary Fibrotic Response. PLoS One. 2016 May 12;11(5):e0154942. doi: 10.1371/journal.pone.0154942. eCollection 2016.
9. Shin D, Lee G, Sohn SH, Park S, Jung KH, Lee JM, Yang J, Cho J (Co-corresponding), Bae H. Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A₂in Mice. Toxins (Basel). 2016 Apr 30;8(5). pii: E131. doi: 10.3390/toxins8050131.
10. Choi SH, Kim SH, Shim KW, Han JW, Choi J, Kim DS, Lyu CJ, Kim JW, Suh CO, Cho J (Corresponding). Treatment Outcome and Prognostic Molecular Markers of Supratentorial Primitive Neuroectodermal Tumors. PLoS One. 2016 Apr 13;11(4):e0153443. doi: 10.1371/journal.pone.0153443.
 11. Cho WH, Cho J (Corresponding). Evolving clinical cancer radiotherapy: Concerns regarding normal tissue protection and quality assurance. J Korean Med Sci. 2016 Feb;31 Suppl 1:S75-87. doi: 10.3346/jkms.2016.31.S1.S75. Review.
12. Cho Y, Chang JS, Rha KH, Hong SJ, Choi YD, Ham WS, Kim JW, Cho J (Corresponding). Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis? PLoS One. 2016 Jan 25;11(1):e0147191. doi: 10.1371/journal.pone.0147191.
13. Park K, Choi W, Keum KC, Lee H, Yoon J, Lee CG, Lee IJ, Cho J (Corresponding). Mechanical quality assurance using light field for linear accelerators with camera calibration. Phys Med. 2016 Feb;32(2):398-402. doi: 10.1016/j.ejmp.2016.01.003.
14. Kim BY, Jin H, Lee YJ, Kang GY, Cho J, Lee YS. Focal exposure of limited lung volumes to high-dose irradiation down-regulated organ development-related functions and up-regulated the immune response in mouse pulmonary tissues. BMC Genet. 2016 Jan 27;17:29. doi: 10.1186/s12863-016-0338-9.
15. Choi SH, Nam JK, Kim BY, Jang J, Jin YB, Lee HJ, Park S, Ji YH, Cho J, Lee YJ. HSPB1 inhibits the endothelial-to-mesenchymal transition to suppress pulmonary fibrosis and lung tumorigenesis. Cancer Res. 2016 Mar 1;76(5):1019-30. doi: 10.1158/0008-5472.CAN-15-0952.
16. Park HH, Roh TH, Kang SG, Kim EH, Hong CK, Kim SH, Ahn SS, Lee SK, Choi HJ, Cho J, Kim SH, Lee KS, Suh CO, Chang JH. Pseudoprogression in glioblastoma patients: the impact of extent of resection. J Neurooncol. 2016 Feb;126(3):559-66. doi: 10.1007/s11060-015-2001-0.
17. Hong ZY, Lee CG, Shim HS, Lee EJ, Song KH, Choi BW, Cho J (Co-corresponding), Story MD. Time, Dose, and Volume Responses in a Mouse Pulmonary Injury Model Following Ablative Irradiation. Lung. Lung. 2016 Feb;194(1):81-90. doi: 10.1007/s00408-015-9825-4.
18. Choi SH, Cho J, Kim JS, Cheong JW, Suh CO. Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience. Radiat Oncol J. 2015 Dec;33(4):310-9. doi: 10.3857/roj.2015.33.4.310.
19. Kang HC, Yu T, Lim do H, Kim IH, Chung WK, Suh CO, Choi BO, Cho KH, Cho JH, Kim JH, Nam DH, Park CK, Hong YK, Kim IA. A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13-12. J Neurooncol. 2015 Oct;125(1):207-15. doi: 10.1007/s11060-015-1902-2.
20. Choi SH, Hong ZY, Nam JK, Lee HJ, Jang J, Yoo RJ, Lee YJ, Lee CY, Kim KH, Park S, Ji YH, Lee YS, Cho J (Co-corresponding), Lee YJ. A Hypoxia-Induced Vascular Endothelial-to-Mesenchymal Transition in Development of Radiation-Induced Pulmonary Fibrosis. Clin Cancer Res. 2015 Aug 15;21(16):3716-26. doi: 10.1158/1078-0432.CCR-14-3193.
21. Lee EJ, Kim JW, Yoo H, Kwak W, Choi W, Cho S, Choi YJ, Lee YJ, Cho J (Corresponding). Single high-dose irradiation aggravates eosinophil-mediated fibrosis through IL-33 secreted from impaired vessels in the skin compared to fractionated irradiation. Biochem Biophys Res Commun. 2015 Aug 14;464(1):20-6. doi: 10.1016/j.bbrc.2015.05.081.
22. Choi C, Park JH, Lee CG, Kim HJ, Suh CO, Cho J (Corresponding). Successful salvage treatment of myxoid liposarcoma with multiple peritoneal seeding using helical tomotherapy-based intraperitoneal radiotherapy: a case report. BMC Res Notes. 2015 May 2;8:179. doi: 10.1186/s13104-015-1134-8.
23. Lee J, Lee J, Choi J, Kim JW, Cho J, Lee CG. Early treatment volume reduction rate as a prognostic factor in patients treated with chemoradiotherapy for limited stage small cell lung cancer. Radiat Oncol J. 2015 Jun;33(2):117-25. doi: 10.3857/roj.2015.33.2.117. Epub 2015 Jun 30.
24. Choi Y, Lee IJ, Lee CY, Cho JH, Choi WH, Yoon HI, Lee YH, Lee CG, Keum KC, Chung KY, Haam SJ, Paik HC, Lee KK, Moon SR, Lee JY, Park KR, Kim YS. Multi-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patients. Radiat Oncol J. 2015 Jun;33(2):75-82. doi: 10.3857/roj.2015.33.2.75. Epub 2015 Jun 30.
25. Yoo H, Kang JW, Lee DW, Oh SH, Lee YS, Lee EJ, Cho J (Corresponding). Pyruvate metabolism: A therapeutic opportunity in radiation-induced skin injury. Biochem Biophys Res Commun. 2015 May 8;460(3):504-10. doi: 10.1016/j.bbrc.2015.03.060. Epub 2015 Mar 19.
26. Hong ZY1, Song KH, Yoon JH, Cho J (Co-corresponding), Story MD. An Experimental Model-Based Exploration of Cytokines in Ablative Radiation-Induced Lung Injury In Vivo and In Vitro. Lung. Lung. 2015 Jun;193(3):409-19. doi: 10.1007/s00408-015-9705-y. Epub 2015 Mar 7.
27. Sohn SH, Lee JM, Park S, Yoo H, Kang JW, Shin D, Jung KH, Lee YS, Cho J (Co-corresponding), Bae H. The inflammasome accelerates radiation-induced lung inflammation and fibrosis in mice. Environ Toxicol Pharmacol. 2015 Mar;39(2):917-26. doi: 10.1016/j.etap.2015.02.019. Epub 2015 Mar 7.
28. Kim KH, Cho BC, Lee CG, Kim HR, Suh YG, Kim JW, Choi C, Baek JG, Cho J (Corresponding). Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases From Lung Adenocarcinoma: Early Response and Dosimetric Evaluation. Technol Cancer Res Treat. 2016 Feb;15(1):122-9. doi: 10.1177/1533034614566993. Epub 2015 Jan 18.
29. Lee H, Kim JW, Hong SJ, Yang SC, Choi YD, Rha KH, Cho J (Corresponding). Adjuvant radiotherapy outcome of stage I testicular seminoma: a single institution study. Yonsei Med J. 2015 Jan 1;56(1):24-30. doi: 10.3349/ymj.2015.56.1.24.
30. Lee DS, Cho J, Kim SH, Kim DS, Shim KW, Lyu CJ, Han JW, Suh CO. Patterns of Failure Following Multimodal Treatment for Medulloblastoma: Long-Term Follow-up Results at a Single Institution Cancer Res Treat. 2015 Oct;47(4):879-88. doi: 10.4143/crt.2014.067. Epub 2014 Dec 8.
31. Suh YG, Kim YS, Suh CO, Kim Y, Cheong JW, Kim J, Cho J (Corresponding). The role of radiotherapy in the management of POEMS syndrome. Radiat Oncol. 2014 Nov 28;9(1):265. [Epub ahead of print]
32. Kim H, Kim JW, Hong SJ, Rha KH, Lee CG, Yang SC, Choi YD, Suh CO, Cho J (Corresponding). Treatment outcome of localized prostate cancer by 70 Gy hypofractionated intensity-modulated radiotherapy with a customized rectal balloon. Radiat Oncol J. 2014 Sep;32(3):187-97. doi: 10.3857/roj.2014.32.3.187. Epub 2014 Sep 30.
33. Yu T, Kang HC, Lim DH, Kim IH, Chung WK, Suh CO, Choi BO, Cho KH, Cho JH, Kim JH, Park CK, Hong YK, Kim IA. Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean radiation oncology group study 13-12. J Neurooncol. 2015 Feb;121(3):531-9. doi: 10.1007/s11060-014-1660-6. Epub 2014 Nov 13.
34. Kim SJ, Yang DH, Kim JS, Kwak JY, Eom HS, Hong DS, Won JH, Lee JH, Yoon DH, Cho J, Nam TK, Lee SW, Ahn YC, Suh C, Kim WS. Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study. Ann Hematol. 2014 Nov;93(11):1895-901. doi: 10.1007/s00277-014-2137-6. Epub 2014 Jun 20.
35. Hong ZY, Lee HJ, Choi WH, Lee YJ, Eun SH, Lee JI, Park KW, Lee JM, Cho J (Corresponding). A preclinical rodent model of acute radiation-induced lung injury after ablative focal irradiation reflecting clinical stereotactic body radiotherapy. Radiat Res. 2014 Jul;182(1):83-91. doi: 10.1667/RR13535.1. Epub 2014 Jun 17.
36. Hong ZY, Eun SH, Park K, Choi WH, Lee JI, Lee EJ, Lee JM, Story DM, Cho J (Corresponding). Development of a small animal model to simulate clinical stereotactic body radiotherapy-induced central and peripheral lung injuries. Journal of Radiation Research 2014 Jul;55(4):648-57. doi: 10.1093/jrr/rrt234. Epub 2014 Feb 20.
37. Cha J, Suh CO, Park K, Chang JH, Lee KS, Kim SH, Chang JS, Kim JH, Suh YG, Kim JW, Cho J (Corresponding). Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report. Yonsei Medical Journal 2014 Jan; 55(1):70-7.
38. Cha H, Kim JW, Suh CO, Kim JS, Cheong JW, Lee J, Keum KC, Lee CG, Cho J (Corresponding). Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study. Radiat Oncol J. 2013 Dec;31(4):177-184.
39. Kim YN, Kim SK, Jeong K, Lee CG, Keum KC, Lee IJ, Cho J (Corresponding). A comparative planning study of step-and-shoot IMRT versus helical tomotherapy in a model patient. Journal of Korean Physical Society 2013 Oct 63(7); 1481-1485.
40. Kim JW, Lee DW, Choi WH, Jeon YR, Kim SH, Cho H, Lee EJ, Hong ZY, Lee WJ, Cho J (Corresponding). Development of a porcine skin injury model and characterization of the dose-dependent response to high-dose radiation. Journal of Radiation Research 2013 Sep 1;54(5);823-31.
41. Lee DS, Kim YS, Lee CG, Lim JH, Suh CO, Kim HJ, Cho J (Corresponding). Early volumetric change and treatment outcome of metastatic brain tumors after external beam radiotherapy: Differential radiotherapy for brain metastasis. Clinical and Translational Oncology 2013 Nov;15(11):889-96.
42. Kim SH, Shim HS, Cho J, Jeong JH, Kim SM, Hong YK, Sung JH, Ha SJ, Kim HR, Chang H, Kim JH, Tania C, Cho BC. A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC). Lung Cancer. 2013 Mar;79(3):270-5.
43. Kim JW, Cho JH, Keum KC, Kim JH, Kim GE, Lee JY, Kim SK, Lee CG. IMRT with simultaneous integrated boost and concurrent chemotherapy for nasopharyngeal cancer: Plan evaluation and treatment outcome. Jpn J Clin Oncol. 2012 Dec; 42 (12): 1152-1160.
44. Kim JW, Kim YB, Choi JJ, Koom WS, Kim H, Kim NK, Ahn JB, Lee I, Cho JH, Keum KC. Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer. Int J of Radiat Oncol Biol Phys. 2012 Dec 1;84(5):e577-84.
45. Suh YG, Suh CO, Kim JS, Kim SJ, P HO, Cho J (corresponding). Radiotherapy for solitary plasmacytoma of bone and soft tissue: Outcomes and prognostic factors. Annals of Hematology. 2012 Nov; 91(11):1785-93.
46. Kim YS, Kim SH, Cho J, Kim JW, Chang JH, Kim DS, Lee KS, Suh CO. MGMT Gene Promoter Methylation as a Potent Prognostic Factor in Glioblastoma Treated with Temozolomide-Based Chemoradiotherapy: A Single-Institution Study. Int J of Radiat Oncol Biol Phys. 2012 Nov 1;84(3):661-7.
47. Kim JW, Kim WC, Cho J, Kim DS, Shim KW, Lyu CJ, Won SC, Suh CO. A Multimodal Approach Including Craniospinal Irradiation Improves the Treatment Outcome of High-risk Intracranial Nongerminomatous Germ Cell Tumors. Int J of Radiat Oncol Biol Phys. 2012 Nov 1;84(3):625-31
48. You SH, Kim SY, Lee CG, Keum KC, Kim JH, Lee IJ, Kim YB, Koom WS, Cho J, Kim GE. Is there a clinical benefit to adaptive planning during tomotherapy in patients with head and neck cancer at risk for xerostomia. American Journal of Clinical Oncology 2012 Jun;35(3):261-6.
49. Cho J, Kodym R, Seliounine S, Richardson JA, Solberg TD, Story MD. High dose-per fraction irradiation of limited lung volumes using image-guided, highly focused irradiator: Simulating stereotactic body radiotherapy regimens in a small animal model. Int J of Radiat Oncol Biol Phys. 2010:77(3);895-902.
50. Kim YB, Hong SJ, Yang SC, Cho J, Choi YD, Kim GE, Rha KH, Han WK, Cho NH, Oh YT. Patterns of failure in bladder cancer patients treated with radical cystectomy: rationale for adjuvant radiotherapy. J Korean Med Sci. 2010:26;835-40.
51. Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh J, Lee SW, Kim JS, Cho J, Lee GW, Kang KM, Eom HS, Pyo HR, Ahn YC, Ko YH, Kim WS. Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study. J Clin Oncol 2009;27(35):6027-32. Epub 2009 Nov 2.
52. Cho J, Lee CG, Kang DR, Kim J, Lee S, Suh CO, Seong J, Suh YG, Lee I, Kim GE. Positional Reproducibility and Effects of a Rectal Balloon in Prostate Cancer Radiotherapy. J Korean Med Sci 2009;24(5):894-903.
53. Kim SY, You SH, Song T, Kim YN, Keum KC, Cho J, Lee CG, Seong J. Superficial dosimtery for helical tomotherapy. J Korean Soc Ther Radiat Oncol 2009;27(2):103-110.
54. DeRose P, Cho J, Choy H. Management of Locally Advanced Non-small Cell Lung Cancer. J Lung Cancer 2009;8(1):1-7.
55. Cho J, Choi JU, Kim DS, Suh CO. Low-dose craniospinal irradiation as a definitive treatment for intracranial germinoma. Radiother Oncol 2009 Apr;91(1):75-9.
56. Lee IJ, Seong JS, Lee CG, Kim YB, Keum KC, Suh CO, Kim GE, Cho JH (corresponding). Early clinical experience and outcome of helical tomotherapy for multiple metastatic lesions. Int J Radiat Oncol Biol Phys 2009 Apr 1;73(5):1517-24.
57. Pyo JY, Cho J, Kim H, Park JP, Kim YT, CHO NH. The Expression of Hypoxia Inducible Factor-1αand Its Correlation with the Expressions of Cyclin A1 and Cyclin B1 and the Clinicopathologic Factors of Uterine Cervical Carcinoma. The Kor J of Pathol 2009;43:13-9
58. Ahn SK, Kim YB, Lee IJ, Song TS, Son DM, Jang YJ, Cho JH, Kim JH, Kim DW, Cho JH (corresponding), Suh CO. Evaluation of a water-based bolus device for radiotherapy to the extremities in Kaposi’s sarcoma patients. J Korean Soc Ther Radiat Oncol 2008;26(3):189-194.
59. Cho JH, Kim GE, Rha KH, Ahn JB, Lee CG, Suh CO, Seong JS, Keum KC, Kim SI, Lee YH. Hypofractionated high-dose intensity-modulated radiotherapy (60 Gy at 2.5 Gy per fraction) for Recurrent Renal Cell Carcinoma: A case report. J Korean Med Sci 2008:23;740-743.
60. Song TS, Suh CO, Lee I, Jeong K, Keum K, Lee CG, Song J, Cho JH (corresponding). The effect of respiratory motion on forward intenstity modulated radiotherapy for breast cancer. Technology Cancer Res Treat. 2008;7(3):207-16.
61. Kim JH, Kim JS, Ha SW, Shin SS, Park W, Cho J, Suh CO, Oh YT, Shin SW, Kim JC, Jang JY, Nam TK, Choi YM, Kim IH. A patterns of care study of the various radiation therapies for prostate cancer among Korean Radiation Oncologists in 2006. J Korean Soc Ther Radiat Oncol 2008;26(2):96-103.
62. Shim KW, Kim TG, Suh CO, Cho JH, Yoo CJ, Choi JU, Kim JH, Kim DS. Treatment failure in intracranial primary germinomas. Child’s Nervous System 2007;23(10):1155-61
63. Kim YB, Cho JH, Keum KC, Lee CG, Seong JS, Suh CO, Kim GE. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors. Gynecol Oncol 2007;104(1):58-63.
64. Ding B, Chi SG, Kim SH, Kang S, Cho JH, Kim DS, Cho NH. Journal of Cell Science. Role of p53 in antioxidant defense of HPV-positive cervical carcinoma cells following H2O2 exposure. Journal of Cell Science 2007;120:2284-94
65. Cho J. Perspectives of Radiotherapy and combined modality treatment of bladder cancer. The Korean Journal of Urological Oncology. 2007;5(Supple 1):88-93
66. Shim SJ, Yang WI, Shin E, Koom WS, Kim YB, Cho JH, Suh CO, Kim JH, Kim GE. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type. 2007;67(1):31-8.
67. Keum KC, Chung EJ, Koom WS, Cho JH, Cho SH, Choi EC, Lee CG, Suh CO, Kim GE. Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer. Otolaryngol Head Neck Surg. 2006 Dec; 135(6):858-64.
68. Cho J. Optimal dose and fractionation size for prostate cancer: Dose escalation and hypofractionation would be beneficial? J Korean Soc Ther Radiol Oncol 2005;24(Supple 1):S20-S21
69. Kim SS, Yang WJ, Cho JH, Hong SJ. The effects of neoadjuvant external beam radiotherapy on pathologic T3 stage T3 bladder transitional cell carcinoma. The Korean Journal of Urology 2006;47(3):232-236
70. Keum KC, Suh YG, Koom WS, Cho JH, Shim SJ, Lee CG, Park CS, Chung WY, Kim GE. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea. Int J of Radiat Oncol Biol Phys 2006;65(2):474-480
71. Cho J. Prostate cancer modalities: In Quest for Standardization. Japanese journal of medical physics 2005; 25(Supple 3-1):13-16.
72. Cho JH, Kim HC, Suh CO, Lee CG, Keum KC, Cho NH, Lee IJ, Shim SJ, Suh YK, Seong J, Kim GE. Optimum Radiotherapy Schedule for Uterine Cervical Cancer based-on the Detailed Information of Dose Fractionation and Radiotherapy Technique. J Korean Soc Ther Radiol Oncol 2005;23(3):143-156
73. Cho JH, Lee CG, Kim KJ, Bak J, Lee SB, Cho SJ, Shim SJ, Yoon DH, Chang JH, Kim TG, Kim DS, Suh CO. Radiation Dose-escalation Trial for Glioblastomas with 3D-Conformal Radiotherapy. J Korean Soc Ther Radiol Oncol 2004;22(4):237-246
74. Cho KS, Yang WJ, Chin OH, Cho JH, Hong SJ. The Clinical Experience of Localized or Locally Advanced Prostate Cancer Treated with Neoadjuvant Hormone Therapy and External Beam Radiotherapy. The Korean Journal of Urological Oncology 2004;2(3):178-182
75. Suh CO, Shin HS, Cho JH, Park W, Ahn SD, Shin KH, Chung EJ, Keum KC, Ha SW, Ahn SJ, Kim WC, Lee MZ, Ahn KJ, Choi DH, Kim JH, Park KR, Lee KK, Kang S, Song MH, Oh DH, Lee JW, Kim IH. The 1998, 1999 patterns of care study for breast irradiation after breast-conserving surgery in Korea. J Korean Soc Ther Radiol Oncol 2004;22(3):192-199
76. Kim GE, Yang W, Lee S, Rha SY, Chung HC, Kim JH, Cho JH, Suh CO, Yoo NC, Roh JK and Hahn J. Lack of Correlation Between P-glycoprotein and Chemotherapy Resistance in Nasal NK/T-cell Lymphomas. Leukemia & lymphoma 2004;45(9):1857-1864
77. Cho JH, Koom WS, Lee CG, Kim KJ, Shim SJ, Bak J, Jeong K, Kim T, Kim DS, Choi J, Suh CO. Analysis of the causes of subfrontal recurrence in medulloblastoma and its salvage treatment. J Korean Soc Ther Radiol Oncol 2004;22(3):175-176
78. Cho JH. Radiation treatment for prostate cancer. Journal of the Koran Medical Association. 2004;47(4):424-431
79. Seong J, Cho JH, Yang WI, Chung EJ, Kim NK. Apoptosis and proliferation in paired primary colorectal adenocarcinomas and their liver metastases. Yonsei medical journal 2004;45(2):187-192
80. Cho JH, Cho KH, Keum KC, Han Y, Kim YB, Chu SS, Suh CO. The benefit of individualized custom bolus in the postmastectomy radiation therapy: Numerical analysis with 3-D treatment planning. J Korean Soc Ther Radiol Oncol 2003;21(1):82-93
81. Han Y, Cho JH, Park HC, Chu SS, Suh CO. Improved breast irradiation techniques using multistatic fields or three dimensional universal compensators. J Korean Soc Ther Radiol Oncol 2002;20(1):24-33
82. Cho JH, Lim J, Seong J, Pyo HR, Koom WS, Suh CO, Hong SJ. Bladder preservation by combined modality therapy for invasive bladder cancer : A five-year follow-up. . J Korean Soc Ther Radiol Oncol 2001;19(4):359-368
83. Seong J, Cho JH, Kim NK, Min JS, Suh CO. Preoperative Chemoradiotherapy with oral doxifluridine plus low-dose oral leucovorin in unresectable primary rectal cancer. Int J of Radiat Oncol Biol Phys 2001;50(2):435-439
84. Park HC, Suh CO, Seong JS, Cho JH, Lim JJ, Park W, Song JS, Kim KE. A Prospective Randomized Comparative Clinical Trial Comparing the Efficacy between Ondansetron and Metoclopamide for Prevention of Nausea and Vomitting in Patients Understanding Fractionated Radiotherapy to the Abdominal Region. J Korean Soc Ther Radiol Oncol 2001;19(2):127-135
85. Cho JH, Kim GE, Cho GH, Lee CG, Kim YB, Lee SW, Keum KC, Suh CO. Hyperfractionated Re-irradiation using a 3-Dimensional Conformal Technique for Locally Recurrent Carcinoma of the Nasophaynx ; Preliminary Results. Yonsei Medical Journal 2001;42(1):55-64
86. Cho JH, Seong JS, Keum KC, Kim GE, Suh CO, Roh JK, Chung HC, Min JS, Kim NK. Efficacy of a Preoperative Concurrent Chemoradiotherapy for the Locally Advanced Unresectable Rectal Cancer. J Korean Soc Ther Radiol Oncol 2000;12(4): 293-299.
87. Lim JH, Kim GE, Keum KC, Suh CO, Lee SW, Park HC, Cho JH, Lee SH, Chang SK, Loh JJK. Parotid Gland Sparing Radiotherapy Technique Using 3-D Conformal Radiotherapy for Nasopharyngeal Carcinoma. J Korean Soc Ther Radiol Oncol 2000;18(1):1-10
88. Kim GW, Cho JH, Yang WI, Chung EJ, Suh CO, Park KR, Hong WP, Park IY, Hahn JS, Roh JK, Kim BS. Angiocentric Lymphoma of the Head and Neck: Patterns of Systemic Failure After Radiation Treatment. Journal of Clinical Oncology 2000;18(1):54-63
89. Kim GE, Chung EJ, Lim JJ, Keum KC, Lee SW, Cho JH, Lee CG, Choi EC. Clinical Significance of Neck Node Metastasis in Squamous Cell Carcinoma of the Maxillary Antrum. American J of Otolaryngology 1999:20(6):383-390
90. Park W, Suh CO, Chung EJ, Cho JH, Kim JH, Chung HC, Roh JK, Hahn JS, Kim GE. The analysis of Treatment Results and Prognostic Factors in Suradiaphragmatic CS I-II Hodgkin’s Disease. J Korean Soc Ther Radiol Oncol 1998;15(4):287-296
91. Lee SW, Kim GE, Keum KC, Park HC, Cho JH, Han SU, Lee KK, Suh CO, Hong WP, Park IY. Clinical Application of 3-D Conformal Radiotherapy for Carcinoma of the Ethmoid Sinus : I. Comparative Analysis Between Conventional 2-D and 3-D Conformal Plans. J Korean Soc Ther Radiol Oncol 1997;15(4):287-296
2017/05/14 23:48 2017/05/14 23:48

댓글을 달아 주세요

코멘트를 남겨주세요

오픈아이디로만 댓글을 남길 수 있습니다

1 2 3 4 5  ... 49 


전체 (49)
조재호교수 소개 (3)
진료시간 및 예약 (1)
국내최초 4세대 전립선암 브라키테라피 (15)
전립선암 (15)
폐암 (4)
뇌종양 (4)
림프혈액암 (1)
언론보도 (4)



«   2019/09   »
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30